Background Rapid eye movement sleep behavior disorder (RBD) is highly comorbid with Parkinson's disease (PD). Emerging evidence suggests that dopamine-replacement therapies (DRTs) for PD may modify the course of RBD, yet the nature of the association between DRTs and RBD remains unclear. To ...
A direct antidepressant effect has been reported for certain dopaminergic medications used in the treatment of Parkinson's disease (PD). To examine whether dopaminergic medications may exert differential effects on mood in early PD. We analyzed prospectively-collected 5-year data on 405 early, drug-...
PARKINSON'S diseaseDOPAMINE agentsThis article explores the challenges posed when ensuring the effective management of patients with Parkinson's in the secondary care setting. The evidence base around the appropriate timing and administration of medications is explored and highlights key themes in the ...
(2009). Dopaminergic medication effects of the speech of individuals with Parkinson''s disease. Journal of Medical Speech-Language Pathology, 17, 125144.Source of funding and disclosure of interest: This study was partially supported by Grant 1-R03-DC007066 from the National Institute on Deafness...
O'Suilleabhain P, Bullard J, Dewey RB. Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications. J Neurol Neurosurg Psychiatry 2001;71:607-10.O'Suilleabhain P, Bullard J, Dewey RB. Proprioception in Parkinson's dis- ease is acutely depressed by dopaminergic ...
Brandon M. PeoplesAuburn University, Auburn, AL.Chris P. HurtUniversity of Alabama at Birmingham, Birmingham, AL.Natasha BrooksUniversity of Alabama at Birmingham, Birmingham, AL.Harrison C. WalkerUniversity of Alabama at Birmingham, Birmingham, AL.Jaimie A. Roper...
Dopaminergic medications are used as first-line treatment for Parkinson's disease (PD). In 1999, a case series was published describing 9 patients who took dopamine agonists (pramipexole or ropinirole) and experienced sudden irresistible sleep attacks. Sleep attacks have subsequently been reported with...
Background: Somatosensory abnormalities contribute to the pathophysiology of Parkinson's disease (PD). The goal of this study was to identify abnormalities in the tactile-evoked activation of the somatosensory and motor cortices in PD, and in a sensorimotor circuit that traverses both of these ...
Due to motor and neuropathological asymmetries, Parkinson's disease (PD) patients with right hemibody onset (RHO) of symptoms may experience greater benefit from dopaminergic enhancing medications, relative to patients with left hemibody onset (LHO). We investigated this possibility by measuring ...
Parkin- sonism Relat Disord. 2015;21(2):120-5.Pagano G, Tan EE, Haider JM, Bautista A, Tagliati M. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease. Parkinsonism Relat Disord 2015; 21: 120-125 [PMID: 25483722 DOI: 10.1016/j.park...